Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 84
Optical Disorders Drugs 78
Oncology Drugs 76
Optical 75
Immune Disorders Drugs 68
Cardiovascular Drugs 45
Dermatological Drugs 38
Musculoskeletal Disorders Drugs 38
Biopharmaceuticals 37
Biotechnology 28
Genomics 28
Clinical Trials 27
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 22
Skin Cancer Drugs 21
Infectious Diseases Drugs 19
Allergy and Immunology 17
Central Nervous System Drugs 17
Respiratory Drugs 17
Gastrointestinal Drugs 14
Allergy Drugs 14
Infusions and Injectables 13
Drugs by Therapeutic Area 11
Lung Cancer Drugs 11
Hematological Drugs 11
Leukemia Drugs 9
Diagnostics 8
Dermatology 8
Oncology 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Needles and Syringes 7
Biosimilars and Biosuperiors 6
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Enzymes 5
Company Reports 4
Therapeutic Area 4
Ovarian Cancer Drugs 4
Cardiovascular Devices 4
Transdermal and Transmucosal Drug Delivery 4
Vaccines 4
Liver and Kidney Disorders Drugs 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Pulmonary Medicine 3
Colon Cancer Drugs 3
Proteomics 3
Drug Delivery 3
Laboratory Equipment 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Diabetes Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Pediatrics 2
Cardiology 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

671 Results (Page 22 of 34)
- Relevance
  Sort by

Atherosclerosis Therapeutics Market 2024-2028

 Report
June 2024
145 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Chronic Obstructive Pulmonary Disease Market Insight, Epidemiology and Market Forecast - 2034

 Report
September 2024
343 Pages
Global

From

€7235EUR$7,950USD£6,203GBP

Exosome Development and Manufacturing Services Market, 2022-2035

 Report
February 2022
209 Pages
Global

From

€4368EUR$4,799USD£3,744GBP

Retinal Vein Occlusion Treatment Market Size, Share & Trends Analysis Report By End-user (Retail Pharmacy, Hospital & Clinics), By Disease Type (CRVO, BRVO), By Treatment (Anti-VEGF, Corticosteroid Drugs), By Region, And Segment Forecasts, 2023 - 2030

 Report
September 2023
180 Pages
Global

From

€5415EUR$5,950USD£4,642GBP

Cell and Gene Therapy Bioassay Services Market by Type of Therapy, Therapeutic Area, Scale of Operation and Geography: Industry Trends and Global Forecasts, 2021-2030

 Report
January 2022
310 Pages
Global

From

€4368EUR$4,799USD£3,744GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

PD-1 & PD-L1 Inhibitors Market by Product, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
194 Pages
Global

From

€3226EUR$3,545USD£2,766GBP

€3585EUR$3,939USD£3,073GBP

Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Fibromyalgia Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Osteoarthritis Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Anti-Inflammatory Drugs Market - Global Outlook & Forecast 2022-2027

 Report
April 2022
326 Pages
Global

From

€3413EUR$3,750USD£2,926GBP

AAV Vector Market: Focus on Drugs, Manufacturers and Technologies by Type of Therapy, Type of Gene Delivery Method Used, Target Therapeutic Area, Application Area, Scale of Operation and Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
August 2022
250 Pages
Global

From

€4368EUR$4,799USD£3,744GBP

Hypophosphatasia Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Skeletal Dysplasia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
180 Pages
Global

From

€4095EUR$4,500USD£3,511GBP

Diabetic Retinopathy Market by Product Type (Anti-VEGF Agents, Corticosteroids, Laser Equipment), Diabetic Type (Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy), Patient Type, End-User - Global Forecast 2025-2030

 Report
March 2025
189 Pages
Global

From

€3226EUR$3,545USD£2,766GBP

€3585EUR$3,939USD£3,073GBP

A Review of the Best Selling Pharmaceutical Drugs in 2021: 2023 Research Report

 Report
February 2023
255 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Viral Clearance and Viral Testing Services Market - Distribution by Scale of Operation, Method of Viral Clearance and Testing, End-User and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

 Report
February 2023
140 Pages
Global

From

€4368EUR$4,799USD£3,744GBP

PD-1 and PD-L1 Inhibitors Market 2024-2028

 Report
October 2024
136 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Investor Series: Opportunities in the Cell and Gene Therapy Market

 Report
April 2022
121 Pages
Global

From

€1728EUR$1,899USD£1,482GBP

Paroxysmal Nocturnal Hemoglobinuria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 Report
May 2024
129 Pages
Global

From

€5915EUR$6,499USD£5,071GBP

Autoimmune Drugs Market 2024-2028

 Report
July 2024
185 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

671 Results (Page 22 of 34)
- 1
- 20
- 21
- 22
- 23
- 24

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.